Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder.

The Journal of Clinical Psychiatry
Rodrigo Machado-VieiraCarlos A Zarate

Abstract

Current therapeutics of depression are similar in their time to antidepressant action and often take weeks to months to achieve response and remission, which commonly results in considerable morbidity and disruption in personal, professional, family, and social life, as well as risk for suicidal behavior. Thus, treatment strategies presenting a rapid improvement of depressive symptoms--within hours or even a few days--and whose effects are sustained would have an enormous impact on public health. This article reviews the published data related to different aspects of rapid improvement of depressive symptoms. Literature for this review was obtained through a search of the MEDLINE database (1966-2007) using the following keywords and phrases: rapid response, antidepressant, time to, glutamate, sleep, therapeutics, latency, and depression. The data obtained were organized according to the following topics: clinical relevance and time course of antidepressant action, interventions showing evidence of rapid response and its potential neurobiological basis, and new technologies for better understanding rapid anti-depressant actions. A limited number of prospective studies evaluating rapid antidepressant actions have been conducted. C...Continue Reading

Citations

Nov 22, 2011·Expert Opinion on Pharmacotherapy·Michele FornaroGiulio Perugi
Oct 21, 2014·PloS One·Selver Demic, Sen Cheng
Nov 12, 2015·Journal of Psychiatric Practice·Ajay K ParsaikSoniya S Mascarenhas
Oct 27, 2016·Expert Review of Clinical Pharmacology·Ioline D HenterRodrigo Machado-Vieira
Feb 22, 2018·Harvard Review of Psychiatry·Ioline D HenterCarlos A Zarate
Apr 3, 2020·Phytotherapy Research : PTR·Laura MicheliStefano Pallanti
Feb 6, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sujung J YoonPerry F Renshaw
Jul 8, 2011·The International Journal of Neuropsychopharmacology·Blynn G Bunney, William E Bunney
Feb 3, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lobna IbrahimCarlos A Zarate
Nov 2, 2013·Expert Review of Neurotherapeutics·Richard WeislerMichael Bauer
Apr 12, 2017·Translational Psychiatry·T D GouldT T Postolache
May 9, 2019·Pharmacology Research & Perspectives·Thomas P Blackburn
Mar 27, 2020·Psychiatry Investigation·Cheolmin Shin, Yong-Ku Kim
Sep 10, 2010·Harvard Review of Psychiatry·Carlos ZarateGiacomo Salvadore
May 28, 2009·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Rodrigo Machado-VieiraCarlos A Zarate
Mar 22, 2014·Biochemical Society Transactions·Katherine M J McMurrayLeigh D Plant
Aug 30, 2012·Journal of Translational Medicine·Rodrigo Machado-Vieira
Apr 3, 2016·Physical Therapy·Cristy Phillips, Ahmad Salehi
Oct 26, 2018·The British Journal of Psychiatry : the Journal of Mental Science·Belinda GrahamLori A Zoellner
Aug 12, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Rafael T de SousaRodrigo Machado-Vieira
Jul 1, 2020·The Journal of International Medical Research·Filip SzkodziakPiotr Szkodziak
Mar 3, 2012·Pharmacogenomics·Sneha Narasimhan, Falk W Lohoff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.